Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page

Eurofins ScientificS.A. Stock

Price
Target price
€543.40

€543.40

-1.520%
-7.8
-1.520%
€777.00

€777.00

 
Latest predictions
-
30.06.20
buy
-
31.05.20
buy
-
03.11.19
buy
€777.00
27.11.17
buy
Your prediction

Eurofins ScientificS.A. Stock

We can see a decrease in the price for Eurofins ScientificS.A.. Compared to yesterday it has lost -€7.800 (-1.520%).
Currently there is a rather positive sentiment for Eurofins ScientificS.A. with 4 Buy predictions and 0 Sell predictions.
With a target price of €777.00 there is a positive potential of 42.989% for Eurofins ScientificS.A. compared to the current price of €543.40.
Register To Post

Other discussions about Eurofins ScientificS.A. Stock

New thread

News

Eurofins Publishes Method for Early Detection of Asymptomatic SARS-CoV-2 Virus Spreaders, That Does Not Require Human PCR Clinical Testing


Regulatory News:



Eurofins (Paris:ERF):



Although employees showing COVID-19 symptoms are currently discouraged from going to work, significant workplace COVID-19 outbreaks continue to occur

Eurofins Technologies Launches Rapid Point-of-Care Testing Devices That Identify Exposure to COVID-19 in Only 10 Minutes


Regulatory News:



Eurofins Technologies (Paris:ERF) announces the launch of CE-IVD marked rapid point-of-care testing devices to identify a person’s past exposure to COVID-19 (SARS-CoV-2) in only

Eurofins Technologies Announces AOAC Performance Tested MethodsSM Status for SENSISpec Ingezim Gluten R5 Kit


Eurofins Technologies, a supplier of test kits and systems for laboratory analyses, announces that its ELISA assay (enzyme-linked immunosorbent assay) for the detection of gluten, SENSISpec Ingezim

Eurofins Technologies Launches Total Antibody (IgG, IgA and IgM) Detection ELISA Assays to Aid the Rapid Identification of Persons Who Have Been Exposed To SARS-CoV-2 (COVID-19)


Eurofins Technologies (Paris:ERF) announces the launch of a serology-based total antibody (IgG, IgA and IgM) detection ELISA assay for indirect diagnostic of past exposure to COVID-19. The

Eurofins Launches Eurofins SAFER@WORK™: A Comprehensive Suite of Risk-Based COVID-19 Safety Solutions for Businesses


Eurofins (Paris:ERF) launched today globally Eurofins SAFER@WORK™, a suite of integrated risk-based solutions for businesses to keep staff and customers safer during the COVID-19 pandemic designed

Eurofins Technologies Launches Multiplex Real-Time PCR Assay for SARS-CoV-2 (Coronavirus) Pathogen Detection


Regulatory News:



Eurofins Technologies (Paris:ERF) announces the launch of its CE-IVD marked multiplex Real-Time RT-PCR (reverse-transcriptase polymerase chain reaction) assay for the direct

Eurofins Scientific to enable over 20 million COVID-19 tests per month by end May 2020 with multiple new solutions


 




  • Today, Eurofins Scientific, a world leader in Testing for Life, employing 47,000 in 800 laboratories in 50 countries published its Q1 trading statement and on this occasion announced a number

Eurofins Technologies’ Range of Testing Kits for Serology-based Antibody Detection by ELISA in Patients Exposed to COVID-19 now Available to Order Online by Government Approved Clinical Laboratories Globally


In a continued effort to help fight the COVID-19 crisis, Eurofins Technologies announces the CE-IVD marking of a first range of testing kits for serology-based antibody detection by ELISA of